Sanofi adopts US FDA-selected flu strains to ensure readiness for the 2025-26 flu season: Bridgewater, New Jersey Monday, March 17, 2025, 14:00 Hrs [IST] Sanofi announced the imme ...
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...
Latigo Biotherapeutics ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain treatments ...
Malignant Infantile Osteopetrosis (MIOP), also known as autosomal recessive osteopetrosis, is a rare genetic disorder that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback